Targeted Therapy Clinical Resource Area

Advances in science have led to the discovery and identification of specific proteins and molecular pathways whose malfunction lead to carcinogenesis. This information has been used to development cancer medications that are able that target the cancer cells without damaging the normal cells, thus leading to less side effects. There are many types of targeted therapies including monoclonal antibodies, targeted kinase inhibitors, Deacetylase inhibitors and Proteasome inhibitors.

Immunotherapy including Monoclonal antibodies, growth factors and vaccines are used to boost or restore the immune systems ability to fight cancer.

Nanotechnology is another emerging field that deals with the he engineering and creation of things from materials that are less than 100 nanometers (one-billionth of a meter) in size, especially single atoms or molecules. Nanotechnology is being studied in the detection, diagnosis, and treatment of cancer.  (Reference)

There are many FDA approved targeted therapies and even more in clinical trials.

ONS SIG
Targeted and Biotherapy SIG